The Maxer Medical Writing team, with the contribution of Annalisa Hinteregger, provided editorial support for the drafting of Integrating the New Pharmacological Standard of Care with Traditional Nutritional Interventions in non-dialysis CKD, an article by Luca De Nicola, Adamasco Cupisti, Claudia D’Alessandro, Loreto Gesualdo, Domenico Santoro, and Vincenzo Bellizzi. The… read more →
Biocure, the Italian branch of the PiLeJe Group, has entrusted Maxer Consulting to implement a project of digital marketing to engage the physicians working within the Italian Medically-Assited Reproduction centres in an educational programme focused on using associated pro-biotics and active substances in addressing successful assisted reproduction. Maxer will also… read more →
On 22 July Massimo Zaninelli, CEO of Maxer Consulting, presented the training session dedicated to “Clinical studies: from submission to AIC” to the young participants of Missione MSL. The lecture outlined the overview of the process that leads from the design of a study to the marketing authorization of the… read more →
By adopting a data-driven, objective method based on public data, Maxer can profile doctors’ behaviours on the web and social media and classify their familiarity with digital media. Based on the results obtained, it is possible to identify each doctor’s favourite channels and media for digital medical-scientific information activity, which… read more →
With the kickoff meeting on March 4th, Zambon S.p.A. started the implementation of the “EMA User Personas Model for the CTIS” project, the organization of which is entrusted to Maxer Consulting. The project, with its focus on communication, training, and organizational alignment activities, is designed to prepare Zambon to manage… read more →
We are pleased to announce that EryDel S.p.A., now part of Quince Therapeutics Inc., has appointed Maxer Consulting to deliver its Clinical Trial Disclosure and Data Transparency program for 2023-24. Maxer will carry out the activities necessary to ensure Erydel’s compliance with both the regulations in force in the European… read more →
We are pleased to announce that Dompé S.p.A. has entrusted Maxer Consulting with implementing the Clinical Trial Disclosure and Data Transparency (CTD/DT) program for 2023-24. CTD’s activities require Maxer to ensure compliance by Dompé with the regulations in force in the European Union (EU Reg. 536/2014) and the United States… read more →
On 25 October, as part of the 2023 Pharmaceutical Marketing Course organized by the Pharma department of AISM Associazione Italiana Sviluppo Marketing, Massimo Zaninelli, CEO of Maxer Consulting, held a lecture dedicated to Digital Pharma Marketing. Among the topics covered in his speech: the fundamentals of digital technologies social media… read more →
